Robyn Wiseman Promoted Within dsm-firmenich’s Biomedical Division

The Biomedical division of dsm-firmenich has named Robyn Wiseman as vice president of Global Commercial, leading the firm’s global commercial team in the Americas, Europe, Middle East, Africa, and Asia-Pacific. 

Wiseman first joined dsm-firmenich in 2020 as director of Commercial Development and took responsibility for several key global accounts. Her work has included collaborating with top OEMs in the orthopedic and cardiovascular space. She was quickly promoted to senior director of Commercial Development in North America, where she built and led the commercial sales team in the region, transforming the function and ultimately leading to significant revenue growth.

With more than 20 years of medical device industry experience, Wiseman has worked for top organizations including Johnson & Johnson, Abbott Vascular, as well as Medtronic. Her experience has given her breadth across the industry including catheter lab and OR sales, partnering with national group purchasing organizations and IDNs, and strategizing with OEM executives. In her last position, as vice president of Global Business Development for Q Medical Devices, Wiseman transformed the sales model by developing processes, implementing critical enablement tools, driving strategy, recruiting, training, and coaching executive-level salespeople worldwide. These roles allowed Wiseman to effectively lead her team to achieve global double-digit growth.

“We are both excited and proud to have such a strong internal candidate to take on this key position for us at Biomedical and we wish Robyn every success in her new position,” dsm-firmenish Biomedical President Paul Spencer said. “We’re confident Robyn will continue to lead our team to new heights and help us to further establish the Biomedical division as a world leader in biomaterials.”

dsm-firmenich reinvents, manufactures, and combines vital nutrients, flavors, and fragrances for the world’s growing population to thrive. dsm-firmenich is a Swiss-Dutch company, listed on the Euronext Amsterdam, with operations in almost 60 countries, revenues of more than €12 billion, and nearly 30,000 employees globally. 

As the world’s biomaterials expert and committed partner in driving sustainable innovation in healthcare, Biomedical is at the forefront of biomaterial science and process innovation. The company’s technologies and support are recognized for its quality, reliability, and performance in multiple markets worldwide.